Peptide Synthesis Market to Grow with a CAGR of 6.81% through 2030
Increasing use of peptides in pharmaceutical and orphan drug
development is expected to drive the Global Peptide Synthesis Market growth in
the forecast period, 2026-2030.
According to TechSci Research report, “Peptide Synthesis
Market - Global Industry
Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Peptide
Synthesis Market stood at USD 524.26 Million in 2024 and is anticipated to grow
with a CAGR of 6.81% in the forecast period through 2030. The rising demand for
peptide molecules in the healthcare and nutrition industries serves as a key
driver for the global peptide synthesis market. Additionally, the increasing
utilization of peptides in therapeutic drug production is expected to fuel market
growth in the coming years. Peptides are increasingly being employed in the
treatment of neurodegenerative and cardiovascular disorders, further contributing
to the expansion of the global peptide synthesis market. Advancements in
peptide synthesis technology have the potential to boost demand and propel
market growth in the future. Furthermore, government initiatives promoting the
benefits of peptide synthesis are anticipated to bolster overall market growth.
The global peptide synthesis
market is highly competitive, with the presence of well-established market
players who have achieved success through consistent results. These players are
expected to hold a significant share of the global market in the future. Growth
strategies such as novel product launches can provide a competitive advantage
to these established players in the peptide synthesis market. For instance,
US-based market player GenScript Biotech announced the launch of the
'Neoantigen Specific Peptide Synthesis Service' in April 2020, aimed at
precision immune-oncology therapeutic development in the next two years.
Prominent players in the peptide synthesis market could consider collaborating
with smaller players to expand their market presence and increase their revenue
shares. Research and development efforts are expected to be a key growth
strategy for established players in the peptide synthesis market. The
increasing adoption of peptide therapies, driven by cost-effectiveness,
efficiency, and lower toxicity, is a major factor contributing to market growth
in the pharmaceutical and biotechnology sectors.
Technological advancements in recent years have brought about significant changes in the pharmaceutical industry, leading to the utilization of synthetic peptides in pharmaceutical medicines. Solid Phase Peptide Synthesis is increasingly being employed in laboratories for the development of synthetic peptides, which play a crucial role in the creation of innovative medications. The research activities conducted on peptides have witnessed a notable increase, accompanied by the growth of public and private entities engaged in synthetic biology research. This trend is expected to fuel the market growth for peptides in the coming years. However, a major challenge faced by the market is the lack of unified regulations governing peptides, making it difficult for them to obtain therapeutic approvals and limiting their application areas.
Moreover, the rising prevalence of eye and skin disorders, coupled with increased research and development activities, significantly impacts the growth of the studied market. Cosmetic peptides, such as Acetyl Tetrapeptide-5 and Dipeptide-2, are widely utilized in eye creams to address dark and puffy under-eye circles by improving lymphatic circulation. Additionally, peptides like oligopeptide-34 and nonapeptide-1 find application in the treatment of skin pigmentation. According to a research article published in the Karger Journal in May 2021, individuals with dark skin of South/Southeast Asian, Hispanic/Latin American, and African descent have a high prevalence of pigmentary disorders. The same source indicates that pigmentary disorders rank as the third and fourth most common dermatoses in Blacks and Hispanics, respectively. Therefore, the high prevalence of pigmentation disorders and the potential benefits of cosmetic peptides in correcting skin pigmentation are expected to drive the cosmetic peptide synthesis market during the forecast period.
Furthermore, numerous studies have demonstrated the ability of peptides to promote wound healing, cell migration, and angiogenesis. Cosmetic peptides find applications in eye care, aging, and pigmentation benefits, and several clinical trials are being conducted to validate their advantages. For instance, a clinical trial published in the Clinical Aesthetic Dermatology Journal in May 2021 introduced an enhanced peptide-based serum that combines five neuromodulating peptides. These peptides target pre- and postsynaptic pathways at the neuromuscular junction to induce muscle relaxation and attenuate facial expression, thereby minimizing the formation of expression lines. Scientific evidence has shown that these peptides have statistically significant effects in reducing the appearance of facial lines, eye lines, and eye wrinkles during maximum smile and facial rest relative to the baseline. The increasing number of trials utilizing cosmetic peptides and the associated advantages are expected to drive market growth during the forecast period.
Browse over XX market data
Figures spread through XX Pages and an in-depth TOC on "Global Peptide Synthesis Market”
The Global Peptide Synthesis
Market is segmented into product, technology, application, end-user, regional
distribution, and company.
Based
on Product, the reagents and consumables segment is experiencing the fastest growth among all product categories. This growth is largely driven by the increasing demand for high-purity materials required for peptide drug development, research, and diagnostic applications. Reagents such as amino acids, resins, coupling agents, and solvents play a critical role in both solid-phase and liquid-phase synthesis processes, making them essential for every stage of peptide production. The rising prevalence of chronic diseases, such as cancer and metabolic disorders, has spurred greater interest in peptide-based therapies, thereby boosting the consumption of reagents and consumables. Additionally, technological advancements in peptide synthesis methods and automation have led to higher throughput and reproducibility, further increasing the usage of these materials. With the growing need for rapid, scalable, and reliable synthesis protocols, laboratories and pharmaceutical companies are investing more in high-quality reagents to meet regulatory standards and ensure product consistency.
Based on region, Asia Pacific is exhibiting the fastest growth in the global peptide synthesis market. This rapid expansion is primarily driven by several key factors including increasing healthcare expenditure, expanding pharmaceutical manufacturing capabilities, rising investment in biotechnology research, and supportive government initiatives across emerging economies such as China, India, South Korea, and Singapore. One of the most significant drivers is the surge in demand for affordable peptide therapeutics due to the growing burden of chronic diseases like cancer, diabetes, and cardiovascular disorders in the region. With a large patient pool and improving diagnostic infrastructure, Asia Pacific offers an attractive market for both domestic and multinational biopharmaceutical companies.
Major companies operating in Global
Peptide Synthesis Market are:
- PolyPeptide Group
- Merck KGaA
- Thermo Fisher Scientific
- Enamine Ltd.
- Alfa Chemistry
- CEM Corporation
- GenScript
- AAPPTec
- Bachem Holding
- AnaSpec, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“There have been significant
technological advancements to facilitate the creation and synthesis of
peptides, which have gained considerable traction in the healthcare and
nutrition sectors. Both enzymatic and chemical peptide synthesis have followed
this trend. The market is experiencing growth due to the utilization of
peptides in the pharmaceutical and consumer healthcare sectors. Peptides have a
diverse range of applications in the treatment of cancer, diabetes, and
obesity, in addition to addressing other lifestyle issues. The increased
prevalence of these metabolic and lifestyle diseases has led to the wider
adoption of peptide treatments in oncology and metabolic illnesses. These peptides can
effectively address signs of aging, enhance skin brightness, soothe dry and
itchy skin, and provide moisturization for individuals of all age groups. The
development of such dermo-cosmetic peptides has the potential to revolutionize
the cosmetics industry, thereby driving segment growth during the analysis
period.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Peptide Synthesis Market- Global Industry
Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Equipment, Reagents and Consumables, Others), By Technology
{Solid-Phase Peptide Synthesis (SPPS), Solution-Phase Synthesis (SPS),
Liquid-Phase Peptide Synthesis (LPPS)}, By Application (Therapeutics, Diagnosis,
Research), By End-User (Pharmaceutical and Biotechnology Companies, Contract
Manufacturing Organization (CMO), Academic and Research Institutes), By Region and Competition, 2020-2030F”, has evaluated the future
growth potential of Global Peptide Synthesis Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Peptide Synthesis Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com